[Sofia, Bulgaria] – Comac Medical proudly welcomes Brian Swindley as our new Global Head of Project Management. Brian will officially join on the 2nd of June, bringing with him three decades of clinical trial leadership experience, with expertise in enhancing operational and commercial functions. With a proven track record of success across nine critical domains, including project management, clinical operations, and proposals and contracts. Brian is uniquely equipped to lead our project teams into a new era of excellence.
Brian Swindley: A Proven Leader with a Mindset for Success
Throughout his 30+ year career, Brian has specialized in building high-performing project ecosystems by integrating streamlined processes, cutting-edge tools, and cultivating a resilient, success-oriented mindset within teams. His approach is rooted in the belief that operational efficiency and team culture are key to long-term project success.
Brian holds an MBA in Project Management and has trained over 1,000 Project Managers globally. His previous roles include serving as a Management Consultant with a focus on performance improvement and participating in over 100 bid defenses as both a functional expert and executive leader. His extensive experience in clinical research and strategic project execution positions him perfectly to advance Comac Medical’s global initiatives.
Brian’s Mindset for Growth
Brian is enthusiastic about joining Comac Medical at a pivotal time of growth and innovation. “Mindset is everything,” he says; a philosophy that guides his leadership style and underpins his vision for building empowered, agile, and motivated project teams. Brian believes Comac Medical is uniquely positioned for tremendous success and is excited to contribute to its mission of operational excellence and client-focused delivery.
About Comac Medical
Comac Medical is a leading clinical research organization (CRO) and site management organization (SMO) with 27 years of experience in delivering high-quality solutions for clinical trials. Headquartered in Bulgaria, the company offers a full range of services across all phases of drug development, including its Early Phase Clinical Research Unit (CRU) specializing in Phase I, Bioavailability, and Bioequivalence (BA/BE) studies, and specializes in clinical operations, data management, regulatory affairs, and site management. Comac Medical partners with global pharmaceutical, biotechnology, and medical device companies to drive innovation, operational excellence, and improved patient outcomes, ensuring successful and efficient trial execution.
For more information, contact marketing@comac-medical.com.
